These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34356140)

  • 1. Utility of Transcranial Magnetic Simulation in Studying Upper Motor Neuron Dysfunction in Amyotrophic Lateral Sclerosis.
    Geevasinga N; Van den Bos M; Menon P; Vucic S
    Brain Sci; 2021 Jul; 11(7):. PubMed ID: 34356140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology.
    Vucic S; Kiernan MC
    Handb Clin Neurol; 2013; 116():561-75. PubMed ID: 24112924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights.
    Vucic S; Ziemann U; Eisen A; Hallett M; Kiernan MC
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1161-70. PubMed ID: 23264687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques.
    van den Bos MAJ; Geevasinga N; Higashihara M; Menon P; Vucic S
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis.
    Vucic S; Kiernan MC
    Clin Neurophysiol; 2008 May; 119(5):1088-96. PubMed ID: 18313980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study.
    Schuster C; Kasper E; Machts J; Bittner D; Kaufmann J; Benecke R; Teipel S; Vielhaber S; Prudlo J
    J Neurol; 2013 Nov; 260(11):2856-64. PubMed ID: 23996101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.
    Agarwal S; Highton-Williamson E; Caga J; Matamala JM; Dharmadasa T; Howells J; Zoing MC; Shibuya K; Geevasinga N; Vucic S; Hodges JR; Ahmed RM; Kiernan MC
    J Neurol; 2018 Aug; 265(8):1819-1828. PubMed ID: 29868980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurophysiological biomarkers in amyotrophic lateral sclerosis.
    Vucic S; Rutkove SB
    Curr Opin Neurol; 2018 Oct; 31(5):640-647. PubMed ID: 30080715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of threshold tracking transcranial magnetic stimulation in ALS.
    Vucic S; van den Bos M; Menon P; Howells J; Dharmadasa T; Kiernan MC
    Clin Neurophysiol Pract; 2018; 3():164-172. PubMed ID: 30560220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-pulse transcranial magnetic stimulation in amyotrophic lateral sclerosis.
    Civardi C; Collini A; Mazzini L; Monaco F; Geda C
    Muscle Nerve; 2020 Mar; 61(3):330-337. PubMed ID: 31837153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional motor cortex dysfunction in amyotrophic lateral sclerosis.
    Menon P; Yiannikas C; Kiernan MC; Vucic S
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1373-1382. PubMed ID: 31402622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical Excitability across the ALS Clinical Motor Phenotypes.
    Dharmadasa T
    Brain Sci; 2021 May; 11(6):. PubMed ID: 34071187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical contributions to the flail leg syndrome: Pathophysiological insights.
    Menon P; Geevasinga N; Yiannikas C; Kiernan MC; Vucic S
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(5-6):389-96. PubMed ID: 26888565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional spreading pattern is associated with clinical phenotype in amyotrophic lateral sclerosis.
    Maranzano A; Verde F; Colombo E; Poletti B; Doretti A; Bonetti R; Gagliardi D; Meneri M; Maderna L; Messina S; Corti S; Morelli C; Silani V; Ticozzi N
    Brain; 2023 Oct; 146(10):4105-4116. PubMed ID: 37075222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Biomarkers for Amyotrophic Lateral Sclerosis.
    Huynh W; Dharmadasa T; Vucic S; Kiernan MC
    Front Neurol; 2018; 9():1141. PubMed ID: 30662429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis.
    Vucic S; Kiernan MC
    J Neurol Neurosurg Psychiatry; 2007 Aug; 78(8):849-52. PubMed ID: 17210625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease.
    Vucic S; Kiernan MC
    Neurotherapeutics; 2017 Jan; 14(1):91-106. PubMed ID: 27830492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history and clinical features of the flail arm and flail leg ALS variants.
    Wijesekera LC; Mathers S; Talman P; Galtrey C; Parkinson MH; Ganesalingam J; Willey E; Ampong MA; Ellis CM; Shaw CE; Al-Chalabi A; Leigh PN
    Neurology; 2009 Mar; 72(12):1087-94. PubMed ID: 19307543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of cortical excitability studies in amyotrophic lateral sclerosis.
    Geevasinga N; Menon P; Yiannikas C; Kiernan MC; Vucic S
    Eur J Neurol; 2014 Dec; 21(12):1451-7. PubMed ID: 24698287
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.